Flt3 ligand enhances thymic-dependent and thymic-independent immune reconstitution.

Blood
Terry J FryCrystal L Mackall

Abstract

Despite recent progress in our understanding of the biology of T-cell homeostasis, clinically available therapies to substantially improve immune reconstitution in patients sustaining T-cell depletion are lacking. T cells are regenerated via a dynamic interplay between thymopoiesis and thymic-independent homeostatic peripheral expansion (HPE). Using athymic mice subjected to T-cell depletion, we observed that HPE is critically dependent on dendritic cells (DCs) for presentation of antigen, raising the possibility that the availability of DCs might be limiting in vivo for HPE to occur efficiently. Indeed, flt3 ligand (flt3L) treatment of athymic mice subjected to T-cell depletion (without DC depletion) substantially enhanced HPE and improved immune competence. Following bone marrow transplantation (BMT) in athymic hosts, both dendritic cells and T cells were profoundly depleted and flt3L therapy restored DC numbers and enhanced HPE. In addition, thymus-bearing BMT recipients treated with flt3L regenerated increased numbers of thymic-dependent progeny with increased numbers of T-cell receptor excision circle (TREC)-positive T cells, indicating increased thymopoiesis. Therefore, flt3L is a potent immunorestorative agent that enhan...Continue Reading

References

Mar 8, 1991·Science·B Rocha, H von Boehmer
Jan 1, 1991·Annual Review of Immunology·R M Steinman
Jan 1, 1995·Annual Review of Immunology·G Pantaleo, A S Fauci
Aug 1, 1995·International Journal of Hematology·S D Lyman
Oct 4, 1996·Science·J D AltmanM M Davis
Feb 1, 1996·Immunological Reviews·P A GleesonI R van Driel
Jun 1, 1997·Immunological Reviews·R Parkman, K I Weinberg
Nov 25, 1998·Bone Marrow Transplantation·Y Sherer, Y Shoenfeld
May 18, 1999·The Journal of Allergy and Clinical Immunology·R GerliC Franceschi
Dec 2, 1999·Nature·A W Goldrath, M J Bevan
Mar 23, 2001·Nature Immunology·K S SchlunsL Lefrançois
May 9, 2001·Blood·T J FryC L Mackall
May 29, 2001·Nature Immunology·B D Walker, B T Korber
Jul 12, 2001·Proceedings of the National Academy of Sciences of the United States of America·J T TanC D Surh
Sep 21, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·H Gudmundsdottir, L A Turka
Sep 21, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·R MaileJ A Frelinger
Sep 21, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·M MillrainP J Dyson
Sep 28, 2001·Trends in Immunology·T J Fry, C L Mackall
Nov 8, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·M PrlicS C Jameson
Mar 21, 2002·Cancer Immunology, Immunotherapy : CII·Muthukumaran SivanandhamMarc K Wallack
Jan 15, 2003·Proceedings of the National Academy of Sciences of the United States of America·Christina T MosesAlexander Khoruts
Jan 18, 2003·Immunity·Booki MinWilliam E Paul
Mar 21, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·George MillerRonald P DeMatteo
Apr 15, 2003·Toxicology and Applied Pharmacology·Tsung-Ming ShihJohn H McDonough

❮ Previous
Next ❯

Citations

Jan 17, 2009·Nature Immunology·Jonathan Kaye
Apr 22, 2011·Nature Reviews. Immunology·Crystal L MackallRonald E Gress
Feb 27, 2008·The Journal of Experimental Medicine·Linda KeninsAleksandra Wodnar-Filipowicz
Nov 30, 2006·Annual Review of Immunology·Lisbeth A WelniakWilliam J Murphy
Nov 29, 2011·Aging Health·Anthony D FosterRonald E Gress
Mar 3, 2007·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·J L ZakrzewskiM R M van den Brink
Jul 8, 2005·Journal of Immunotherapy·Martin GuimondCrystal L Mackall
Oct 21, 2015·Proceedings of the National Academy of Sciences of the United States of America·Martijn H BrugmanFrank J T Staal
Jan 10, 2012·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Darius SairafiMehmet Uzunel
Sep 20, 2011·Best Practice & Research. Clinical Haematology·Jarrod A Dudakov, Marcel R M van den Brink
May 3, 2011·Blood Cells, Molecules & Diseases·Emmanuelle M SixIsabelle André-Schmutz
Nov 21, 2007·Seminars in Immunology·Ann ChidgeyRichard Boyd
Oct 13, 2005·Experimental Hematology·Francis Hérodin, Michel Drouet
Oct 7, 2015·Frontiers in Immunology·Arnon Dias JurbergVinícius Cotta-de-Almeida
Jul 8, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Simon-David GauthierMartin Guimond
Dec 24, 2011·International Journal of Radiation Biology·Vijay K SinghMark H Whitnall
Jun 4, 2015·Bone Marrow Transplantation·E VelardiM R M van den Brink
Apr 19, 2016·Immunological Reviews·Mohammed S ChaudhryMarcel R M van den Brink
May 8, 2010·Current Opinion in Pharmacology·Georg A HolländerBruce R Blazar
Dec 8, 2015·Hematology·Marcel R M van den BrinkMiguel-Angel Perales
May 21, 2010·Current Opinion in Pharmacology·Tracy S P HengRichard L Boyd
Dec 21, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Mohammed S ChaudhryMarcel R M van den Brink
Mar 22, 2005·Bone Marrow Transplantation·J J Auletta, H M Lazarus
Oct 21, 2009·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Tracy S P HengRichard L Boyd
Jul 23, 2005·International Reviews of Immunology·Maria A Curotto de LafailleJuan J Lafaille
Mar 5, 2005·Blood·Rafik TerraClaude Perreault
Aug 24, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Evert-Jan WilsJan J Cornelissen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.